It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. Zacks Premium also includes the Zacks Style Scores. What ar ...

PLANO, Texas, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced participation at the Wells Fargo 2024 Healthcare Conference, to be held Sept. 4 – 6, 2024, in Boston. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present on Wednesday, Sept. 4, at 2:15 pm EDT. Investor Relations: Andrew Senn andrew.senn@integer.net 763.951.8312 Media Relations: Kelly B ...

Integer Holdings (ITGR) witnessed strong momentum year to date. Shares of the company have gained 21.9% compared with 5.4% growth of the industryin the same time frame. The S&P 500 Composite has risen 14.3% during the same period. With healthy fundamentals and strong growth opportunities, this Zacks Rank #3 (Hold) company appears to be a solid wealth creator for its investors at the moment. Plano, TX-based Integer Holdings manufactures and develops medical devices and components primarily for original equip ...

Core Insights - Zacks Premium provides various tools for investors to enhance their stock market strategies and confidence [1] - The Zacks Style Scores serve as complementary indicators to the Zacks Rank, helping investors select stocks with high potential for market outperformance [2] Zacks Style Scores Overview - Stocks are rated based on value, growth, and momentum characteristics, with scores ranging from A to F, where A indicates the highest potential for outperformance [3] - The Style Scores are categorized into four types: Value Score, Growth Score, Momentum Score, and VGM Score [3][4][5] Value Score - Focuses on identifying undervalued stocks using financial ratios such as P/E, PEG, Price/Sales, and Price/Cash Flow [3] Growth Score - Concentrates on a company's financial health and future growth potential, analyzing projected and historical earnings, sales, and cash flow [4] Momentum Score - Targets stocks with upward or downward price trends, utilizing short-term price changes and earnings estimate adjustments to identify optimal buying opportunities [4] VGM Score - Combines all three Style Scores to provide a comprehensive rating, helping investors find stocks with attractive value, strong growth forecasts, and promising momentum [5] Zacks Rank Integration - The Zacks Rank is a proprietary model based on earnings estimate revisions, with 1 (Strong Buy) stocks achieving an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [6][7] - Investors are encouraged to focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B for the best chances of high returns [9] Company Spotlight: Integer Holdings Corporation (ITGR) - Integer Holdings Corporation, based in Plano, TX, specializes in manufacturing medical devices and components for OEMs [11] - ITGR holds a Zacks Rank of 3 (Hold) and has a VGM Score of A, with a Momentum Style Score of A, reflecting a 3.2% increase in shares over the past four weeks [11][12] - Recent upward revisions in earnings estimates for fiscal 2024 have increased the Zacks Consensus Estimate by $0.04 to $5.31 per share, with an average earnings surprise of 7.8% [12]

~ Report Highlights Integer's Commitment to Minimizing Environmental Footprint, Maximizing Positive Global Impact and Enhancing the Lives of Patients Worldwide ~ PLANO, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced the release of its first environmental, social and governance (ESG) report, "Making a Difference: Integer's Inaugural Impact Report." "I am excited to ...

Core Insights - Integer Holdings Corporation has released its first environmental, social, and governance (ESG) report titled "Making a Difference: Integer's Inaugural Impact Report" [1][2] - The report emphasizes the company's commitment to minimizing its environmental footprint while enhancing the lives of patients and communities globally [1][2] Environmental and Social Commitment - The report outlines Integer's initiatives in health and safety, diversity and inclusion, associate engagement, charitable initiatives, and volunteerism [1] - The company employs over 11,000 associates across four continents, highlighting its global operational reach and commitment to patient care [2] Strategic Partnerships - Integer positions itself as a strategic partner for medical device companies and original equipment manufacturers (OEMs), focusing on innovative and high-quality product solutions [4]

Company Overview - Integer Holdings Corporation (ITGR) is based in Plano, TX, and specializes in manufacturing and developing medical devices and components primarily for original equipment manufacturers (OEMs) [16]. Investment Insights - ITGR currently holds a Zacks Rank of 3 (Hold) and has a VGM Score of A, indicating strong potential for growth investors [13][14]. - The company is forecasted to achieve year-over-year earnings growth of 13.7% for the current fiscal year, supported by a Growth Style Score of B [13]. - In the last 60 days, four analysts have revised their earnings estimates higher for fiscal 2024, with the Zacks Consensus Estimate increasing by $0.04 to $5.31 per share [17]. - ITGR has demonstrated an average earnings surprise of 7.8%, suggesting a positive trend in earnings performance [17].

Core Viewpoint - Integer Holdings reported strong financial performance in the second quarter of 2024, with notable growth in its Medical Sales segment, although overall revenues slightly missed expectations [22][14]. Revenue Analysis - Revenues increased by 9% year over year, totaling $436.2 million, but fell short of the Zacks Consensus Estimate by 0.4% [14]. - Medical Sales generated revenues of $427.4 million, reflecting a 9.8% increase year over year and a 5.9% organic growth [3]. - The Cardio and Vascular (C&V) business reported revenues of $231.3 million, up 10.9% year over year [18]. - The Cardiac Rhythm Management & Neuromodulation (CRM&N) business achieved revenues of $167.6 million, up 9.3% year over year [5]. - Non-Medical segment revenues decreased by 19.3% year over year, totaling $8.8 million, attributed to a normalization of Electrochem sales [19]. Margin Analysis - Adjusted operating profit reached $56.2 million, a 30.3% increase from the prior year, with an adjusted operating margin of 12.9%, expanding by 211 basis points [7]. - Gross profit was $119.4 million, up 12.8% year over year, with a gross margin of 27.4%, an increase of 92 basis points [20]. Financial Position - Cash and cash equivalents at the end of Q2 2024 were $34.1 million, down from $42.2 million at the end of Q1 2024 [8]. - Total debt decreased slightly to $1.12 billion from $1.14 billion at the end of Q1 2024 [8]. - Cumulative net cash flow from operating activities was $70.5 million, compared to $62.3 million a year ago [21]. 2024 Guidance - The company revised its full-year adjusted EPS guidance to a range of $5.07-$5.49, indicating a rise of 9-18% from 2023 [10]. - Revenue expectations for 2024 are set between $1,735 million and $1,770 million, implying a 9-11% improvement from 2023 [23]. Strategic Developments - Integer Holdings continues to benefit from strong demand across all markets and the recent acquisitions of InNeuroCo and Pulse, which are expected to positively impact the stock [11].

Integer Holdings Corporation (NYSE:ITGR) Q2 2024 Earnings Conference Call July 25, 2024 9:00 AM ET Company Participants Andrew Senn - Senior Vice President, Strategy, Business Development and Investor Relations Joseph Dziedzic - President and Chief Executive Officer Diron Smith - Chief Financial Officer Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Craig Bijou - BofA Securities Matthew O’Brien - Piper Sandler Companies Richard Newitter - Truist Securities Kristen Stewart - C.L. King & ...

The reported revenue represents a surprise of -0.44% over the Zacks Consensus Estimate of $438.15 million. With the consensus EPS estimate being $1.24, the EPS surprise was +4.84%. Here is how Integer performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Shares of Integer have returned +8.5% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could under ...